BOTOX for the Treatment of Urinary Incontinence due to Neurogenic Detrusor Overactivity in Patients with Multiple Sclerosis.
Latest Information Update: 02 May 2019
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurogenic bladder; Urinary incontinence
- Focus Registrational; Therapeutic Use
- Sponsors Allergan
- 20 Jul 2018 Results published in the Neurology
- 10 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov .
- 11 Mar 2014 Planned end date changed from 1 Jun 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov.